Heres where weve narrowed down the results
While ongoing monitoring of calcitonin during GLP-1 therapy is not standard practice, patients should receive education about thyroid cancer warning signs and the importance of reporting new symptoms
Nevertheless, commenting on the work, Professor David Attwell, Jodrell professor of physiology at UCL and study co-lead, said: With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of no-reflow in [myocardial infarction] patients, offering a potentially life-saving solution. Reference Mastitskaya S et al
Most importantly, the patient reported a complete absence of alcohol withdrawal symptoms and a total cessation of the "desire to drink"
doi: 10.1001/jama.2021.1831 11 JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
The medication has garnered substantial attention not only for its effectiveness in managing diabetes but also for its remarkable weight loss benefits